{
  "@context": {
    "dcterms": "http://purl.org/dc/terms/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "xsd": "http://www.w3.org/2001/XMLSchema#",
    "m3": "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M3_GenesisSpace.jsonld#",
    "m2": "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M2_MetaConcepts.jsonld#",
    "m1:core": "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M1_CoreConcepts.jsonld#",
    "m1:biology": "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M1_extensions/M1_Biology.jsonld#",
    "m0:complex_chemical_synapse": "https://raw.githubusercontent.com/Echopraxium/tscg/main/system-models/poclets/complex_chemical_synapse/M0_ComplexChemicalSynapse.jsonld#"
  },
  "@graph": [
    {
      "@id": "m0:complex_chemical_synapse:BloodPressureControl",
      "@type": "owl:Ontology",
      "dcterms:title": "Blood Pressure Control Poclet - TSCG M0 Layer",
      "dcterms:description": "Poclet modeling long-term arterial blood pressure regulation through 5 physiological effector systems: RAAS, Sympathetic NS, ADH, Natriuretic Peptides, and Cardiac Output/Volemia. Demonstrates multi-scale homeostatic control (seconds to days).",
      "dcterms:creator": "Echopraxium with the collaboration of Claude AI",
      "dcterms:created": "2026-01-22",
      "dcterms:modified": "2026-01-22",
      "owl:versionInfo": "1.0.0",
      "owl:imports": [
        "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M1_CoreConcepts.jsonld",
        "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M2_MetaConcepts.jsonld",
        "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/M1_extensions/M1_Biology.jsonld"
      ],
      "rdfs:seeAlso": "https://raw.githubusercontent.com/Echopraxium/tscg/main/ontology/poclets/blood_pressure_control/M0_BloodPressureControl_README.md",
      "rdfs:comment": "This poclet captures the coordinated action of 5 parallel regulatory systems maintaining arterial blood pressure homeostasis. It is the first physiological poclet in TSCG and demonstrates the highest effector count (5 vs 3-4 in other poclets). Validated against Guyton's quantitative model (1972) and clinical evidence from antihypertensive drug trials.",
      "m0:pocletType": "Physiological Homeostasis",
      "m0:domain": "Cardiovascular Physiology / Renal Physiology / Endocrinology",
      "m0:complexity": "High (5 effectors, 3 timescales)",
      "m0:clinicalRelevance": "Maximal (hypertension affects 30-40% of adults worldwide)",
      "m2:ontologyCategory": "Poclet"
    },
    {
      "@id": "m0:blood_pressure_control:BloodPressureControl",
      "@type": [
        "owl:NamedIndividual",
        "m1:core:Poclet"
      ],
      "rdfs:label": "Blood Pressure Homeostasis (5-Effector System)",
      "rdfs:comment": "Long-term regulation of arterial blood pressure through coordinated action of RAAS, Sympathetic NS, ADH, Natriuretic Peptides, and Cardiac Output. Set-point: ~120/80 mmHg in humans. Pathology: Chronic hypertension from dysregulation.",
      "m0:phenomenon": {
        "name": "Long-term Blood Pressure Regulation",
        "description": "Maintenance of stable arterial pressure through multi-scale feedback loops",
        "timescale": "Seconds (neural) to days (renal)",
        "setpoint": "120/80 mmHg (systolic/diastolic in humans)",
        "controlled_variable": "Mean arterial pressure (MAP)",
        "pathology": "Chronic hypertension (>140/90 mmHg) from effector dysregulation"
      },
      "m0:effector_count": 5,
      "m0:effectors": [
        {
          "@id": "m0:blood_pressure_control:RAAS"
        },
        {
          "@id": "m0:blood_pressure_control:Sympathetic"
        },
        {
          "@id": "m0:blood_pressure_control:ADH"
        },
        {
          "@id": "m0:blood_pressure_control:NatriureticPeptides"
        },
        {
          "@id": "m0:blood_pressure_control:CardiacOutput"
        }
      ],
      "m0:asfid_analysis": {
        "m3:A": {
          "value": 0.85,
          "interpretation": "Strong homeostatic attractor at ~120/80 mmHg. Multiple negative feedback loops (baroreceptor reflex, RAAS, ANP) stabilize pressure. Pathological attractor in hypertension (vascular remodeling creates new stable state).",
          "formula": "A = Σ(Feedback_strength × Attractor_depth)",
          "manifestation": "Set-point with basin of attraction (~100-140 mmHg systolic)"
        },
        "m3:S": {
          "value": 0.8,
          "interpretation": "5-effector parallel network with hierarchical organization (fast neural, medium hormonal, slow renal). Anatomical components: heart, kidneys, vessels, adrenal glands, baroreceptors.",
          "formula": "S = Network_complexity × Hierarchical_depth",
          "manifestation": "Convergent topology (5 → 1 controlled variable)"
        },
        "m3:F": {
          "value": 0.9,
          "interpretation": "Multiple flows: Blood (5 L/min cardiac output), hormones (renin, angiotensin, aldosterone, ADH, ANP), renal filtrate (180 L/day). Intercompartmental fluid shifts (vascular ↔ interstitial ↔ intracellular).",
          "formula": "F = Σ(Flux_rates) × Exchange_surface",
          "manifestation": "High exchange across compartments"
        },
        "m3:I": {
          "value": 0.85,
          "interpretation": "Rich information processing. Primary signal: arterial pressure (baroreceptors). Hormonal cascades (RAAS), neural signals (sympathetic), feedback loops (ANP response to volume overload).",
          "formula": "I = Shannon_entropy(signals) × Feedback_loop_count",
          "manifestation": "Frequency-coded (neural) + concentration-coded (hormonal) signals"
        },
        "m3:D": {
          "value": 0.75,
          "interpretation": "Multi-scale dynamics: Fast (seconds - baroreceptor reflex), Medium (minutes-hours - RAAS/ADH), Slow (hours-days - renal excretion). Pathological bifurcation: normotension → hypertension.",
          "formula": "D = Σ(dState/dt) across all timescales",
          "manifestation": "Three distinct kinetic regimes"
        },
        "completeness": "FULL - All 5 ASFID dimensions present and non-trivial"
      },
      "m0:orive_analysis": {
        "m3:O": {
          "value": 0.85,
          "interpretation": "Highly observable. Direct pressure measurement (sphygmomanometer, arterial catheter), cardiac output (echocardiography), hormones (blood sampling). Some components harder to observe (neural activity, local paracrine signaling).",
          "limitations": "Baroreceptor firing requires invasive recording"
        },
        "m3:R": {
          "value": 0.8,
          "interpretation": "Excellent reproducibility. Universal mechanism in mammals. Validated experimental models (Goldblatt hypertension, DOCA-salt). Guyton's mathematical model (1972) quantitatively reproduced.",
          "limitations": "Individual variability (genetics, age, comorbidities)"
        },
        "m3:I": {
          "value": 0.9,
          "interpretation": "Outstanding interoperability. Links cardiovascular + renal + endocrine + neural physiology. Applicable across species (human, rat, dog). Compatible with homeostasis, cybernetics, systems biology frameworks.",
          "strengths": "Central hub connecting multiple physiological domains"
        },
        "m3:V": {
          "value": 0.9,
          "interpretation": "Highly validated. Decades of empirical research. Quantitative predictions (Guyton's pressure-natriuresis curve). Clinical validation through antihypertensive drugs (ACE inhibitors, beta-blockers, diuretics all work as predicted).",
          "strengths": "Molecular targets identified (AT1 receptor, β1-adrenergic receptor)"
        },
        "m3:E": {
          "value": 0.75,
          "interpretation": "Good expressiveness. Extensible (can add kallikrein-kinin, endothelin, NO systems). Detail-oriented (RAAS expandable to Ang(1-7)/Mas axis). Applicable to pathologies (heart failure, CKD).",
          "limitations": "Complexity explosion when adding fine details"
        },
        "global_score": 0.84,
        "interpretation": "High-quality Map - Strong empirical grounding, excellent interoperability, well-validated"
      },
      "m0:epistemic_gap": {
        "value": 0.16,
        "calculation": "Δε = 1 - ORIVE_global = 1 - 0.84 = 0.16",
        "interpretation": "Low epistemic gap - Excellent Territory-Map alignment. The conceptual model (Map) closely matches observable physiology (Territory).",
        "quality": "High alignment"
      },
      "m0:bicephalous_perspective": {
        "dominant": "Territory (Eagle Eye)",
        "rationale": "Strongly rooted in observable physiological phenomena. Quantitative experimental data abundant. Mathematical models validated (Guyton's ODEs). Parameters measurable.",
        "map_quality": "Strong (ORIVE = 0.84)",
        "verdict": "Territory-Dominant Poclet with High-Quality Map"
      },
      "m0:m2_metaconcepts_mobilized": [
        {
          "@id": "m2:Homeostasis",
          "role": "CENTRAL - Core regulatory principle",
          "formula": "A⊗S⊗F",
          "manifestation": "Multi-effector system maintaining pressure within narrow range"
        },
        {
          "@id": "m2:Balance",
          "role": "CENTRAL - Equilibrium between opposing forces",
          "formula": "A⊗S⊗F",
          "manifestation": "Vasoconstriction ↔ Vasodilation, Retention ↔ Excretion"
        },
        {
          "@id": "m2:Regulation",
          "role": "CENTRAL - Active control mechanisms",
          "formula": "A⊗S⊗F",
          "manifestation": "Neural, hormonal, renal control loops"
        },
        {
          "@id": "m2:Network",
          "role": "Distributed architecture",
          "formula": "S⊗I⊗F",
          "manifestation": "5 parallel effectors converging on arterial pressure"
        },
        {
          "@id": "m2:Feedback",
          "role": "Self-regulation",
          "formula": "A⊗I⊗D",
          "manifestation": "Baroreceptor reflex, ANP response to volume overload"
        },
        {
          "@id": "m2:Trade-off",
          "role": "Conflicting optimization criteria",
          "formula": "R⊗V⊗E / A⊗I",
          "manifestation": "Speed vs Robustness (sympathetic fast but unstable, renal slow but robust)"
        },
        {
          "@id": "m2:Hierarchy",
          "role": "Levels of control",
          "formula": "S⊗A",
          "manifestation": "Tier 1: Neural (seconds), Tier 2: Hormonal (minutes-hours), Tier 3: Renal (hours-days)"
        },
        {
          "@id": "m2:Cascade",
          "role": "Sequential signal amplification",
          "formula": "S⊗I⊗D",
          "manifestation": "RAAS enzymatic cascade (Renin → Angiotensinogen → Ang I → Ang II → Aldosterone)"
        },
        {
          "@id": "m2:Threshold",
          "role": "Switching behavior",
          "formula": "A⊗I",
          "manifestation": "Baroreceptor firing threshold (~60-180 mmHg), ANP secretion threshold"
        },
        {
          "@id": "m2:Dynamics",
          "role": "Temporal evolution",
          "formula": "D⊗F",
          "manifestation": "Multi-scale kinetics (fast neural, medium hormonal, slow renal)"
        },
        {
          "@id": "m2:Bifurcation",
          "role": "Qualitative state transition",
          "formula": "∂D/∂F",
          "manifestation": "Normotension → Hypertension (irreversible via vascular remodeling)"
        },
        {
          "@id": "m2:Memory",
          "role": "System retains past states",
          "formula": "∫(D-F)dτ",
          "manifestation": "Vascular remodeling, baroreceptor resetting in chronic hypertension"
        }
      ],
      "m0:m1_concepts_used": {
        "m1:biology:Paracrine": "Local angiotensin II in kidneys and vessels",
        "m1:biology:Endocrine": "Circulating aldosterone, ADH, ANP",
        "m1:physio:BaroreflexArc": "PROPOSED - Baroreceptors → Vasomotor center → Sympathetic output",
        "m1:physio:RenalAutoregulation": "PROPOSED - Myogenic + tubuloglomerular feedback",
        "m1:physio:CardiacOutput": "PROPOSED - CO = HR × SV",
        "m1:physio:PressureNatriuresis": "PROPOSED - Intrinsic renal pressure-dependent sodium excretion"
      },
      "m0:gamification_potential": {
        "score": 5,
        "modes": [
          {
            "name": "Physiologist",
            "objective": "Maintain BP at 120/80 mmHg for 24h",
            "mechanics": "5 sliders to modulate effectors, random perturbations (stress, exercise)",
            "learning": "Multi-scale dynamics, trade-offs, redundancy"
          },
          {
            "name": "Clinician",
            "objective": "Treat hypertensive patient (160/100) with minimal side effects",
            "mechanics": "Prescribe drugs (ACE inhibitor, beta-blocker, diuretic), manage contraindications",
            "learning": "Drug mechanisms, side effects, combination therapy"
          },
          {
            "name": "Pathology Explorer",
            "objective": "Investigate how lesions cause hypertension",
            "scenarios": [
              "Renal artery stenosis → ↑ RAAS",
              "Heart failure → ↑ RAAS + ↑ Sympathetic",
              "Pheochromocytoma → ↑↑ Sympathetic"
            ],
            "learning": "Pathophysiology, root cause vs symptoms"
          },
          {
            "name": "Research Lab",
            "objective": "Virtual experiments to test hypotheses",
            "examples": [
              "Is RAAS necessary? → Block completely, observe",
              "Remove baroreceptors → Increased BP variability",
              "ANP alone sufficient? → Disable others, test"
            ],
            "learning": "Scientific method, systems thinking, historical studies"
          }
        ]
      },
      "m0:scientific_validation": {
        "key_references": [
          {
            "author": "Guyton, A.C.",
            "year": 1972,
            "title": "Arterial Pressure and Hypertension",
            "contribution": "Quantitative model of long-term BP regulation (pressure-natriuresis curve)"
          },
          {
            "author": "Laragh, J.H.",
            "year": 1985,
            "title": "The renin system and four lines of hypertension research",
            "contribution": "RAAS central role in hypertension pathophysiology"
          },
          {
            "author": "Cowley, A.W.",
            "year": 1992,
            "title": "Long-term control of arterial blood pressure",
            "contribution": "Integration of neural, hormonal, and renal mechanisms"
          }
        ],
        "clinical_validation": {
          "ACE_inhibitors": "Reduce BP by blocking Ang II formation - VALIDATED",
          "Beta_blockers": "Reduce BP by blocking sympathetic drive - VALIDATED",
          "Diuretics": "Reduce BP by decreasing volemia - VALIDATED",
          "note": "All 5 effectors targetable by FDA-approved drugs"
        }
      },
      "m0:future_extensions": [
        "Add endothelial regulation (NO, endothelin)",
        "Model circadian variation (BP dipping at night)",
        "Include genetic polymorphisms (renin, ACE, angiotensinogen genes)",
        "Link to chronic kidney disease (bidirectional causality)",
        "Separate poclets: Cardiac Output (Starling curve), RAAS Cascade, Baroreceptor Reflex"
      ]
    },
    {
      "@id": "m0:blood_pressure_control:RAAS",
      "@type": "owl:NamedIndividual",
      "rdfs:label": "Renin-Angiotensin-Aldosterone System (RAAS)",
      "rdfs:comment": "Hormonal cascade controlling volemia and vasoconstriction. Initiated by renin secretion from juxtaglomerular cells in response to decreased renal perfusion. Cascade: Renin → Angiotensinogen → Ang I → ACE → Ang II → Aldosterone.",
      "m0:effector_type": "Hormonal cascade",
      "m0:primary_action": "↑ Volemia (aldosterone → Na/H2O retention) + ↑ Vasoconstriction (Ang II)",
      "m0:timescale": "Minutes to hours",
      "m0:trigger": "↓ Renal perfusion pressure (sensed by juxtaglomerular apparatus)",
      "m0:cascade_steps": [
        "Renin (kidney) cleaves angiotensinogen → Angiotensin I",
        "ACE (lung endothelium) cleaves Ang I → Angiotensin II",
        "Ang II stimulates aldosterone secretion (adrenal cortex)",
        "Aldosterone → ↑ Na reabsorption (distal tubule) → ↑ H2O retention → ↑ Volemia",
        "Ang II → Vasoconstriction (AT1 receptors on smooth muscle)"
      ],
      "m0:pharmacological_targets": [
        "ACE inhibitors (e.g., enalapril) - block Ang I → Ang II",
        "AT1 receptor blockers (e.g., losartan) - block Ang II binding",
        "Renin inhibitors (e.g., aliskiren) - block angiotensinogen cleavage",
        "Aldosterone antagonists (e.g., spironolactone) - block mineralocorticoid receptor"
      ],
      "m0:m2_metaconcepts": [
        "m2:Cascade (S⊗I⊗D) - Sequential enzymatic amplification",
        "m2:Regulation (A⊗S⊗F) - Hormonal control mechanism",
        "m2:Signal (I⊗F) - Hormonal information carrier"
      ],
      "m0:pathology": "Hyperactivation in renovascular hypertension (renal artery stenosis), heart failure, cirrhosis"
    },
    {
      "@id": "m0:blood_pressure_control:Sympathetic",
      "@type": "owl:NamedIndividual",
      "rdfs:label": "Sympathetic Nervous System",
      "rdfs:comment": "Rapid neural reflex controlling heart rate and vascular tone. Baroreceptor arc: Aortic/carotid baroreceptors → Vasomotor center (medulla) → Sympathetic efferents → Norepinephrine release.",
      "m0:effector_type": "Neural reflex",
      "m0:primary_action": "↑ Heart Rate (β1-adrenergic) + ↑ Vasoconstriction (α1-adrenergic)",
      "m0:timescale": "Seconds",
      "m0:trigger": "↓ Arterial pressure detected by baroreceptors",
      "m0:reflex_arc": [
        "Baroreceptors (aortic arch, carotid sinus) sense ↓ BP → ↓ firing rate",
        "↓ Afferent signal to vasomotor center (NTS in medulla)",
        "Vasomotor center → ↑ Sympathetic outflow (RVLM activation)",
        "Sympathetic efferents → Norepinephrine release at heart and vessels",
        "β1 receptors (heart) → ↑ HR + ↑ Contractility → ↑ Cardiac Output",
        "α1 receptors (vessels) → Vasoconstriction → ↑ Total Peripheral Resistance"
      ],
      "m0:pharmacological_targets": [
        "Beta-blockers (e.g., metoprolol) - block β1 receptors",
        "Alpha-blockers (e.g., doxazosin) - block α1 receptors",
        "Centrally-acting agents (e.g., clonidine) - reduce sympathetic outflow from brainstem"
      ],
      "m0:m2_metaconcepts": [
        "m2:Feedback (A⊗I⊗D) - Negative feedback loop (↑BP → ↓Sympathetic)",
        "m2:Threshold (A⊗I) - Baroreceptor firing threshold (~60-180 mmHg)",
        "m2:Dynamics (D⊗F) - Fastest effector (seconds timescale)"
      ],
      "m0:pathology": "Overactivation in heart failure (compensatory response becomes maladaptive)"
    },
    {
      "@id": "m0:blood_pressure_control:ADH",
      "@type": "owl:NamedIndividual",
      "rdfs:label": "Anti-Diuretic Hormone (ADH / Vasopressin)",
      "rdfs:comment": "Peptide hormone secreted by posterior pituitary. Primary role: water retention via V2 receptors in kidney collecting duct. Secondary role: vasoconstriction via V1 receptors in vascular smooth muscle.",
      "m0:effector_type": "Hormonal (peptide)",
      "m0:primary_action": "↑ Water Retention (V2 receptors → aquaporin-2 insertion) + Vasoconstriction (V1 receptors)",
      "m0:timescale": "Minutes to hours",
      "m0:trigger": "↑ Plasma osmolality (detected by hypothalamic osmoreceptors) OR ↓ Blood volume (detected by atrial stretch receptors)",
      "m0:mechanism": [
        "Osmoreceptors (hypothalamus) sense ↑ osmolality → Stimulate ADH secretion",
        "ADH circulates to kidneys",
        "V2 receptors (collecting duct) → ↑ Aquaporin-2 expression → ↑ Water reabsorption",
        "↑ Water retention → ↑ Blood volume → ↑ BP",
        "V1 receptors (vascular smooth muscle) → Vasoconstriction → ↑ TPR → ↑ BP"
      ],
      "m0:pharmacological_targets": [
        "V2 agonists (e.g., desmopressin) - treat diabetes insipidus",
        "V2 antagonists (e.g., tolvaptan) - treat hyponatremia, heart failure"
      ],
      "m0:m2_metaconcepts": [
        "m2:Signal (I⊗F) - Hormonal information carrier",
        "m2:Flow (F) - Regulates water flux across collecting duct",
        "m2:Regulation (A⊗S⊗F) - Osmotic/volumetric control"
      ],
      "m0:pathology": "Excessive secretion (SIADH - syndrome of inappropriate ADH) causes hyponatremia"
    },
    {
      "@id": "m0:blood_pressure_control:NatriureticPeptides",
      "@type": "owl:NamedIndividual",
      "rdfs:label": "Natriuretic Peptides (ANP, BNP)",
      "rdfs:comment": "Counter-regulatory hormones secreted by heart in response to volume/pressure overload. ANP (atrial natriuretic peptide) from atria, BNP (brain natriuretic peptide) from ventricles. Action: ↑ Sodium/water excretion + vasodilation → ↓ BP.",
      "m0:effector_type": "Hormonal counter-regulation",
      "m0:primary_action": "↑ Na/Water Excretion (kidney) + Vasodilation → ↓ Blood Pressure",
      "m0:timescale": "Hours",
      "m0:trigger": "↑ Atrial/ventricular stretch (volume overload or pressure overload)",
      "m0:mechanism": [
        "Atrial/ventricular myocytes sense stretch → Secrete ANP/BNP",
        "ANP/BNP bind NPR-A receptors (kidney, vessels)",
        "Kidney: ↑ GFR + ↓ Sodium reabsorption (inhibit aldosterone) → ↑ Natriuresis/diuresis",
        "Vessels: Vasodilation (via cGMP pathway) → ↓ TPR",
        "Net effect: ↓ Blood volume + ↓ TPR → ↓ BP"
      ],
      "m0:pharmacological_targets": [
        "Neprilysin inhibitors (e.g., sacubitril) - prevent ANP/BNP degradation, used in heart failure"
      ],
      "m0:m2_metaconcepts": [
        "m2:Balance (A⊗S⊗F) - Counter-balances RAAS/Sympathetic vasoconstriction",
        "m2:Feedback (A⊗I⊗D) - Negative feedback (↑Volume → ↑ANP → ↓Volume)",
        "m2:Homeostasis (A⊗S⊗F) - Maintains fluid/pressure homeostasis"
      ],
      "m0:pathology": "Resistance in heart failure (blunted natriuretic response despite high ANP/BNP levels)"
    },
    {
      "@id": "m0:blood_pressure_control:CardiacOutput",
      "@type": "owl:NamedIndividual",
      "rdfs:label": "Cardiac Output & Volemia",
      "rdfs:comment": "Downstream hemodynamic parameters controlled by effectors 1-4. Cardiac Output (CO) = Heart Rate × Stroke Volume. Blood volume (volemia) determines venous return and preload (Starling mechanism). MAP = CO × Total Peripheral Resistance.",
      "m0:effector_type": "Hemodynamic parameter (downstream controlled variable)",
      "m0:formula": "CO = HR × SV (Heart Rate × Stroke Volume)",
      "m0:blood_pressure_equation": "MAP = CO × TPR (Mean Arterial Pressure = Cardiac Output × Total Peripheral Resistance)",
      "m0:controlled_by": [
        "Heart Rate: Sympathetic (↑ via β1) + Parasympathetic (↓ via muscarinic M2)",
        "Stroke Volume: Preload (volemia via Starling curve) + Contractility (sympathetic β1) + Afterload (TPR)",
        "Volemia: RAAS (↑), ADH (↑), ANP (↓), Renal excretion"
      ],
      "m0:starling_mechanism": "↑ Venous return → ↑ End-diastolic volume (preload) → ↑ Stroke Volume (within physiological limits)",
      "m0:m2_metaconcepts": [
        "m2:Flow (F) - Blood flow (5 L/min in resting human)",
        "m2:State (I) - Hemodynamic state (CO, SV, HR as state variables)",
        "m2:Dynamics (D⊗F) - Temporal evolution of cardiac output"
      ],
      "m0:clinical_measurement": [
        "Cardiac Output: Echocardiography (Doppler), thermodilution (Swan-Ganz catheter)",
        "Blood volume: Indicator dilution techniques, estimated from hematocrit",
        "Stroke Volume: Echocardiography (EDV - ESV)"
      ]
    }
  ]
}